Poljak Mario, Kocjan Bostjan J, Kovanda Anja, Lunar Maja M, Lepej Snjezana Zidovec, Planinic Ana, Seme Katja, Vince Adriana
Institute of Microbiology and Immunology, University of Ljubljana, Slovenia.
J Clin Microbiol. 2009 Aug;47(8):2611-5. doi: 10.1128/JCM.00278-09. Epub 2009 Jun 3.
A genotyping study of 285 Hybrid Capture 2 low-risk probe cocktail-positive specimens showed cross-reactivity with several untargeted human papillomavirus genotypes. Cross-reactivity was often clinically beneficial due to the detection of untargeted low-risk genotypes. A total of 8.4% of positive results, usually weak, were due to cross-reactivity with high-risk genotypes. Establishment of a gray zone is recommended.
一项对285份杂交捕获2低风险探针混合检测呈阳性样本的基因分型研究显示,其与几种非靶向人乳头瘤病毒基因型存在交叉反应性。由于检测到非靶向低风险基因型,交叉反应性通常在临床上有益。共有8.4%的阳性结果(通常较弱)是由于与高风险基因型的交叉反应性所致。建议建立一个灰区。